{
    "clinical_study": {
        "@rank": "77462", 
        "brief_summary": {
            "textblock": "Genetically inherited heart diseases like hypertrophic cardiomyopathy (HCM) are conditions\n      affecting the heart passed on to family members by abnormalities in genetic information.\n      These conditions are responsible for many heart related deaths and illnesses.\n\n      Presently, there are several research studies being conducted in order to improve the\n      understanding of disease processes and symptoms associated with genetically inherited heart\n      diseases.\n\n      This study is designed to determine the eligibility of patients diagnosed with or suspected\n      to have inherited heart disease to participate in these research studies."
        }, 
        "brief_title": "Screening for Inherited Heart Disease", 
        "completion_date": "April 2003", 
        "condition": [
            "Heart Disease", 
            "Hypertrophic Cardiomyopathy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cardiomyopathy, Hypertrophic", 
                "Heart Diseases", 
                "Hypertrophy", 
                "Cardiomyopathies"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with hypertrophic cardiomyopathy (HCM) and other inherited cardiac diseases are\n      being studied under several research protocols to determine their pathogenesis and clinical\n      manifestations.  The purpose of this protocol is to determine the eligibility of patients\n      with known or suspected inherited heart conditions for our research protocols."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "INCLUSION CRITERIA\n\n        Subjects and family members known or suspected to have inherited a cardiac disease such as\n        HCM.\n\n        EXCLUSION CRITERIA\n\n        Patients with cardiac conditions that are not known to be inherited."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001746", 
            "org_study_id": "980102", 
            "secondary_id": "98-H-0102"
        }, 
        "keyword": [
            "Hypertrophic Cardiomyopathy", 
            "HCM", 
            "Evaluation for Research", 
            "Medical Advice"
        ], 
        "lastchanged_date": "March 4, 2008", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Heart, Lung and Blood Institute (NHLBI)"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Evaluation of Patients With Known or Suspected Inherited Heart Disease (Screening Protocol)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "3547130", 
                "citation": "Maron BJ, Bonow RO, Cannon RO 3rd, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med. 1987 Mar 26;316(13):780-9. Review. No abstract available."
            }, 
            {
                "PMID": "7671349", 
                "citation": "Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation. 1995 Oct 1;92(7):1680-92. Review."
            }, 
            {
                "PMID": "1975599", 
                "citation": "Solomon SD, Jarcho JA, McKenna W, Geisterfer-Lowrance A, Germain R, Salerni R, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest. 1990 Sep;86(3):993-9."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001746"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "April 1998", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "April 2003"
    }, 
    "geocoordinates": {
        "National Heart, Lung and Blood Institute (NHLBI)": "38.985 -77.095"
    }
}